Astellas mulls darexaban alliances as pipeline moves forward
This article was originally published in Scrip
Executive Summary
Astellas is considering entering into global development and commercialisation alliances for its novel anticoagulant darexaban maleate following a regulatory setback in Japan earlier this year.